106 related articles for article (PubMed ID: 10933146)
1. On interleukin-8, neutrophil activation, and bronchiolitis obliterans syndrome in lung transplantation.
Riise GC
Transplantation; 2000 Jul; 70(2):265-6. PubMed ID: 10933146
[No Abstract] [Full Text] [Related]
2. The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation.
Elssner A; Vogelmeier C
Transpl Infect Dis; 2001 Sep; 3(3):168-76. PubMed ID: 11493399
[TBL] [Abstract][Full Text] [Related]
3. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.
Meloni F; Vitulo P; Cascina A; Oggionni T; Bulgheroni A; Paschetto E; Klersy C; D'Armini AM; Fietta A; Bianco AM; Arbustini E; Viganò M
J Heart Lung Transplant; 2004 Sep; 23(9):1053-60. PubMed ID: 15454171
[TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.
Slebos DJ; Postma DS; Koëter GH; Van Der Bij W; Boezen M; Kauffman HF
J Heart Lung Transplant; 2004 May; 23(5):532-40. PubMed ID: 15135367
[TBL] [Abstract][Full Text] [Related]
5. The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.
Hardison MT; Galin FS; Calderon CE; Djekic UV; Parker SB; Wille KM; Jackson PL; Oster RA; Young KR; Blalock JE; Gaggar A
J Immunol; 2009 Apr; 182(7):4423-31. PubMed ID: 19299743
[TBL] [Abstract][Full Text] [Related]
6. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung.
Riise GC; Williams A; Kjellström C; Schersten H; Andersson BA; Kelly FJ
Eur Respir J; 1998 Jul; 12(1):82-8. PubMed ID: 9701419
[TBL] [Abstract][Full Text] [Related]
7. Lung transplantation. Bronchiolitis obliterans syndrome.
Corris PA
Chest Surg Clin N Am; 2003 Aug; 13(3):543-57. PubMed ID: 13678312
[TBL] [Abstract][Full Text] [Related]
8. Lung transplantation: opportunities for research and clinical advancement.
Magro CM; Pope-Harman AL; Abbas AE; Ross P
Am J Respir Crit Care Med; 2006 Feb; 173(4):466-7; author reply 467. PubMed ID: 16467179
[No Abstract] [Full Text] [Related]
9. Survival after bronchiolitis obliterans syndrome.
Yerkovich ST; Hopkins PM; Chambers DC
Am J Respir Crit Care Med; 2011 Feb; 183(4):554; author reply 554-5. PubMed ID: 21325085
[No Abstract] [Full Text] [Related]
10. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
[TBL] [Abstract][Full Text] [Related]
11. IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome.
Keane MP; Gomperts BN; Weigt S; Xue YY; Burdick MD; Nakamura H; Zisman DA; Ardehali A; Saggar R; Lynch JP; Hogaboam C; Kunkel SL; Lukacs NW; Ross DJ; Grusby MJ; Strieter RM; Belperio JA
J Immunol; 2007 Jan; 178(1):511-9. PubMed ID: 17182591
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
[TBL] [Abstract][Full Text] [Related]
13. Elevated peptides in lung lavage fluid associated with bronchiolitis obliterans syndrome.
Stone MD; Harvey SB; Nelsestuen GL; Reilly C; Hertz MI; Wendt CH
PLoS One; 2014; 9(1):e84471. PubMed ID: 24392140
[TBL] [Abstract][Full Text] [Related]
14. Presence of donor-specific alloreactivity in histologically normal lung allografts is predictive of subsequent bronchiolitis obliterans.
Zeevi A; Rabinowich H; Yousem SA; Paradis IL; Dauber JH; Kormos R; Armitage J; Hardesty R; Griffith B; Duquesnoy RJ
Transplant Proc; 1991 Feb; 23(1 Pt 2):1128-9. PubMed ID: 1989166
[No Abstract] [Full Text] [Related]
15. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.
Estenne M; Maurer JR; Boehler A; Egan JJ; Frost A; Hertz M; Mallory GB; Snell GI; Yousem S
J Heart Lung Transplant; 2002 Mar; 21(3):297-310. PubMed ID: 11897517
[No Abstract] [Full Text] [Related]
16. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients.
Belperio JA; DiGiovine B; Keane MP; Burdick MD; Ying Xue Y; Ross DJ; Lynch JP; Kunkel SL; Strieter RM
Transplantation; 2002 Feb; 73(4):591-9. PubMed ID: 11889437
[TBL] [Abstract][Full Text] [Related]
18. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
[TBL] [Abstract][Full Text] [Related]
19. Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation.
Jaramillo A; Smith MA; Phelan D; Sundaresan S; Trulock E; Lynch J; Cooper J; Patterson GA; Mohanakumar T
Transplant Proc; 1999; 31(1-2):185-6. PubMed ID: 10083069
[No Abstract] [Full Text] [Related]
20. Lymphocyte subset populations in bronchiolitis obliterans after heart-lung transplantation.
Holland VA; Cagle PT; Windsor NT; Noon GP; Greenberg SD; Lawrence EC
Transplantation; 1990 Dec; 50(6):955-9. PubMed ID: 2124009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
